Charles Schoch - 15 Jan 2025 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Interim Chief Financial Officer
Signature
/s/ Charles Schoch
Issuer symbol
CADL
Transactions as of
15 Jan 2025
Net transactions value
-$68,717
Form type
4
Filing time
17 Jan 2025, 16:30:06 UTC
Previous filing
10 Jan 2025
Next filing
14 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CADL Common Stock Sale $68,717 -9,511 -18% $7.22 43,038 15 Jan 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.

Remarks:

Interim Chief Financial Officer